Expansion Potential of Austrian Pharmaceutical Industry in Japan

Companies › Health Care ♦ Published: December 1, 2010; 11:09 ♦ (Vindobona)

Japanese pharmaceutical companies need new products and international cooperation. An opportunity for local companies.

Expansion Potential of Austrian Pharmaceutical Industry in Japan / Picture: © Vindobona.org

"The Japanese health care market is one of the largest in the world. The pharmaceutical market alone is estimated at eight trillion yen -about € 73 billion- in the second place globally after the U.S., and offers many opportunities for Austrian companies", reports Martin Glatz, Austrian Trade Commissioner in Tokyo.

With a rapidly aging population -in 2050 every third Japanese…

or Log In

Fast News Search
Related News
Roche Lays Off 400 Jobs in Styria (November 18, 2010)
Strong Growth of Austria's Export Figures (November 10, 2010)
Unexpected Rise in Research Expenditure (November 4, 2010)
FDI - Austrian enterprises still expanding abroad; foreign enterprises in Austria stagnate (October 5, 2010)
Humanomed Takes Over Management of Private Clinics in the CEE Region (September 28, 2010)
Foreign Direct Investments (FDI) Declined by 80% (September 22, 2010)
Read More
Constitutional Court of Austria VfGH, Japan, R & D, Venture Capital, Joint Ventures, Foreign Trade, FDI Foreign Direct Investments, Health Policy, Pharmaceutical Industry, High Tech Industry
Featured
See latest Vindobona Newsletter